Claims for Patent: 9,796,712

Summary for Patent: 9,796,712

Title:	Heteroaryl compounds for kinase inhibition
Abstract:	Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.
Inventor(s):	Wei-Sheng Huang, Yongjin GONG, Feng Li, Nicholas E. BENCIVENGA, David C. Dalgarno, Anna Kohlmann, William C. Shakespeare, Ranny M. Thomas, Xiaotian Zhu, Angela V. WEST, Willmen Youngsaye, Yun Zhang, Tianjun Zhou
Assignee:	Takeda Pharmaceutical Co Ltd
Application Number:	US15/600,023
Patent Claims:	1. A compound selected from: or a pharmaceutically acceptable salt thereof. 2. The compound or pharmaceutically acceptable salt of claim 1, which is 3. The compound or pharmaceutically acceptable salt of claim 1, which is 4. The compound or pharmaceutically acceptable salt of claim 1, which is 5. The compound or pharmaceutically acceptable salt of claim 1, which is 6. The compound or pharmaceutically acceptable salt of claim 1, which is 7. The compound or pharmaceutically acceptable salt of claim 1, which is 8. The compound or pharmaceutically acceptable salt of claim 1, which is 9. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 2, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 10. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 3, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 11. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 4, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 12. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 5, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 13. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 6, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 14. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 7, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 15. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 8, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.